Enzymatic antioxidant balance and cognitive decline in aging – the EVA study

Abstract
We studied whether primary enzymatic antioxidant protection should influence cognitive decline (CD) in subjects aged 62–72 years volunteers in the Etude du Vieillissement Antériel (EVA) cohort. At...